A possible role for the adenylcyclase system in insulin secretion
- PMID: 4294054
- PMCID: PMC292923
- DOI: 10.1172/JCI105663
A possible role for the adenylcyclase system in insulin secretion
Abstract
A possible role for adenylcyclase in insulin secretion was investigated. Isoproterenol, a predominantly beta-adrenergic agent, when mixed with an alpha-adrenergic blocking agent (phenoxybenzamine), stimulated insulin secretion from pieces of the rat's pancreas in vitro. Theophylline, caffeine, 3'5'-cyclic AMP, glucagon, adrenocorticotropin (ACTH), and thyrotropin (TSH), all of which are thought to act through the adenylcyclase systems in the liver and adipose tissue, also stimulated insulin secretion in vitro; oxytocin and vasopressin, which do not stimulate lipolysis in adipose tissue, were inactive. In all cases, stimulation of insulin secretion could not be detected when glucose was absent or present in only low concentrations (less than 100 mg/100 ml) and was maximal at high levels of glucose (300 mg/100 ml). When pancreatic tissue was obtained from normoglycemic rats and contained no detectable glycogen in the Islets, the stimulant effects of glucose and of theophylline were reduced or abolished by mannoheptulose and 2-deoxyglucose. When tissue was derived from rats infused for 8-10 hr with glucose and contained glycogen, theophylline, even in the absence of glucose, stimulated secretion and this effect was reduced by 2-deoxyglucose but not by mannoheptulose. It is suggested that the beta-cell contains an adenylcyclase system through which phosphorylase and possibly phosphofructokinase could be activated; and that insulin secretion could depend upon and be regulated by hormones and other substances which influence the rate at which glycolysis proceeds within the beta-cell.
Similar articles
-
Inhibition of glucagon secretion.Adv Pharmacol. 2005;52:151-71. doi: 10.1016/S1054-3589(05)52008-8. Adv Pharmacol. 2005. PMID: 16492545 Review.
-
Studies on the role of cyclic AMP in human lipolysis.Adv Cyclic Nucleotide Res. 1972;1:63-85. Adv Cyclic Nucleotide Res. 1972. PMID: 4353189 No abstract available.
-
Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat.Br J Pharmacol. 1997 Jun;121(4):751-8. doi: 10.1038/sj.bjp.0701204. Br J Pharmacol. 1997. PMID: 9208144 Free PMC article.
-
Effect of adrenergic agents on toad bladder response to ADH, 3',5'-AMP, and theophylline.Am J Physiol. 1968 Nov;215(5):1024-31. doi: 10.1152/ajplegacy.1968.215.5.1024. Am J Physiol. 1968. PMID: 4301186 No abstract available.
-
Regulation of insulin secretion.Pharmacol Rev. 1969 Sep;21(3):183-212. Pharmacol Rev. 1969. PMID: 4310138 Review. No abstract available.
Cited by
-
Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.J Clin Invest. 1976 Jan;57(1):230-43. doi: 10.1172/JCI108264. J Clin Invest. 1976. PMID: 173741 Free PMC article.
-
Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.Diabetologia. 1975 Aug;11(4):301-5. doi: 10.1007/BF00422395. Diabetologia. 1975. PMID: 1107120
-
Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate.Biochem J. 1973 Jun;134(2):481-7. doi: 10.1042/bj1340481. Biochem J. 1973. PMID: 16742808 Free PMC article.
-
The glycolytic cascade in pancreatic islets.Diabetologia. 1982 Jul;23(1):1-5. doi: 10.1007/BF00257721. Diabetologia. 1982. PMID: 6214444 Review. No abstract available.
-
[Animal experimental studies on the chronic toxicity of coffee and caffeine].Z Ernahrungswiss. 1973 Dec;12(4):252-60. doi: 10.1007/BF02020645. Z Ernahrungswiss. 1973. PMID: 4781865 German. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources